Medical Condition News

RSS

NCQA recognizes three additional MetCare centers as PPC-PCMH

Metropolitan Health Networks, Inc., a leading provider of health care services in Florida, today announced that an additional three of its centers have been recognized by the National Committee for Quality Assurance (NCQA) as Physician Practice Connections - Patient-Centered Medical Homes.

5 Nov 2011

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

The combination of chemotherapy and radiation significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma (NPC), according to a phase III study published Nov. 4 in the Journal of the National Cancer Institute.

5 Nov 2011

HeRO graft device provides long-term AV access for hemodialysis patients

University Hospitals Case Medical Center physicians are utilizing a novel approach to solve a long standing problem for chronic kidney disease patients on hemodialysis.

5 Nov 2011

Octapharma receives FDA approval for octagam to treat disorders of immune system

The U.S. Food and Drug Administration (FDA) yesterday cleared the way for the U.S. market return of octagam, the Octapharma USA product used to treat disorders of the immune system.

5 Nov 2011

Janssen receives FDA approval for Xarelto to prevent stroke in people with AF

The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm.

5 Nov 2011

Active ingredient in saffron shows promise against MS

Medical researchers at the University of Alberta have discovered that an active ingredient in the Persian spice saffron may be a potential treatment for diseases involving neuroinflammation, such as multiple sclerosis.

5 Nov 2011

X-ray crystallography identifies structure of apoA-I molecule

Using a sophisticated technique of x-ray crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from Boston University School of Medicine (BUSM) have for the first time obtained an "image" of the structure and the precise arrangement of the atoms in a truncated form of the apolipoprotein A-I (apoA-I) molecule.

5 Nov 2011

Obesity affecting wealthy, middle classes more than poor in developing countries, study says

"'First world' health problems such as obesity and heart disease may be gaining ground in developing nations, but they are mostly afflicting the rich and middle class while poor people remain undernourished and underweight," according to a study published in the American Journal of Clinical Nutrition, Reuters reports.

5 Nov 2011

Common gut pathogen increases activity of SMO gene and causes colon tumors

Working with lab cultures and mice, Johns Hopkins scientists have found that a strain of the common gut pathogen Bacteroides fragilis causes colon inflammation and increases activity of a gene called spermine oxidase (SMO) in the intestine.

5 Nov 2011

Arginase-2 enzyme plays a major role in diabetic nephropathy

The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

5 Nov 2011

Heidelberg scientists identify single protein responsible for varicose veins

Dr. Thomas Korff and his group at the Division of Cardiovascular Physiology of Heidelberg University's Institute of Physiology and Pathophysiology have now shown that the pathological remodeling processes causing varicose veins are mediated by a single protein.

5 Nov 2011

Daily intake of Souvenaid improves memory in people with mild AD

A second clinical trial of the medical food Souvenaid confirmed that daily intake of the nutritional intervention improves memory in people with mild Alzheimer's disease.

5 Nov 2011

Miracor's PICSO system safe and feasible during elective PCI

Miracor Medical Systems announced today that data will be reported during next week's "TCT (Transcatheter Cardiovascular Therapeutics) 2011" scientific meeting in San Francisco.

5 Nov 2011

Toxoplasma gondii directly affects production of dopamine in brain

A research group from the University of Leeds has shown that infection by the brain parasite Toxoplasma gondii, found in 10-20 per cent of the UK's population, directly affects the production of dopamine, a key chemical messenger in the brain.

5 Nov 2011

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.

5 Nov 2011

New UBC technology can accurately detect brain aneurysms

University of British Columbia researchers have developed new technology for monitoring brain aneurysms - an approach that is potentially less invasive and more accurate than current methods, and one that is simple enough for patients to use at home for frequent monitoring.

5 Nov 2011

Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. today announced positive data from its 72-patient, Phase 2 clinical trial with RGN-259, a sterile, preservative-free eye drop, to evaluate its safety and efficacy for the treatment of signs and symptoms of dry eye syndrome over a treatment period of 30 days using the Controlled Adverse Environment (CAE) model.

5 Nov 2011

MicroRNAs may predict risk of recurrence in post-resection gastric cancer patients

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to predict the risk of recurrence.

4 Nov 2011

Psychotherapy could have diverse cerebral effects depending on certain genes

Problems like anxiety and depression are caused by psychological and environmental factors, and are known to be influenced by genetic proclivities. However, it is still not clear how each factor affects the brain's functions to induce anxious and depressive symptoms.

4 Nov 2011

Quanticel, Celgene and Versant enter collaboration to discover and develop first-in-class cancer drugs

Privately held biotechnology company Quanticel Pharmaceuticals Inc. and Celgene Corporation, together with Versant Ventures, today announced they have entered into an exclusive, strategic collaboration to discover and develop first-in-class cancer drugs.

4 Nov 2011